Back to mobile site

Harmony Biosciences Holdings Inc. (HRMY) PT Raised to $37 at Raymond James

April 30, 2024 12:17 PM EDT Send to a Friend
Raymond James analyst Danielle Brill raised the price target on Harmony Biosciences Holdings Inc. (NASDAQ: HRMY) to $37.00 (from $34.00) ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login